Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Promethazin (ATC-Code: N05CM22).

Conclusion of a non-exclusive discount contract pursuant to § 130a (8) SGB V for medicinal products with the active substance Promethazin (ATC Code: N05CM22) for the period from 01.07.2026 to 30.06.2028 with the possibility of concluding the contract at any time during the contract period (open-house model).